Detecting and Monitoring Scoliosis Without Radiography: Standard Radiographic Monitoring Program Versus Self-Screening with Momentum SpineTM

NCT ID: NCT06825611

Last Updated: 2025-03-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-03-15

Study Completion Date

2027-08-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is for the Momentum SpineTM application to accurately detect scoliosis progression, including accuracy, margin of error, sensitivity, specificity, AUC, and overall agreement with radiographs in 8-18 year olds with adolescent idiopathic scoliosis. The main question it aims to answer \[is/are\]:

* Based on previous data it is hypothesize that Momentum SpineTM imaging software will be able to accurately detect scoliosis progression (\>= 7 degrees), including accuracy, margin of error, sensitivity, specificity, AUC, and overall agreement with radiographs.
* Based on the above hypothesis that Momentum SpineTM is able to accurately detect scoliosis and curve progression (\>= 7 degrees).
* It is hypothesized there will be indications for accelerated clinical visits based on at home detection of progression, and that these visits will be accurate and necessary.
* It is hypothesized that there will be a proportion of standard care visits that are deemed unnecessary, and that the application is able to accurately predict these visits.

Participants will:

* Use Momentum SpineTM assessment from home to perform body scans at 1-month intervals on personal device and during the clinical visit.
* Received monthly scans that will be evaluated by the provider using the application.
* Receive additional scans as warranted.
* Complete net promoter score (NPS) within the application following completion of a body scan.
* Complete a patient satisfaction survey following 6 months of application usage.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adolescent Idiopathic Scoliosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Momentum Application

Patients diagnosed with scoliosis between 8-18 years of age

Group Type EXPERIMENTAL

Momentum Application

Intervention Type DEVICE

A mobile application to scan and predict spinal curvature. The application monitors curvature and track changes over time.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Momentum Application

A mobile application to scan and predict spinal curvature. The application monitors curvature and track changes over time.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children between the ages of 8-18 years of age
* Confirmed radiographic diagnosis of adolescent idiopathic scoliosis
* No history of spinal/ chest surgery.
* Participants who have had spine x-rays ±1 week as baseline visit at CHLA will be included in the study.
* Participants who have identifiable markings such as tattoos or birthmarks can be included in the study, though their markings will be covered with tape.

Exclusion Criteria

* Participants who have had x-rays in a brace will not be included.
* Participants who have had an x-ray from another institution will not be included in the study. X-rays from out of community are typically done with a different and lower quality machine then the one at our institution. Additionally, we do not have consent from outside institutions to use their x-rays for research purposes.
* Participants with a confirmed pregnancy will not be included. Pregnancy status will be self-reported by participants.
* Participants with the existence of a second deformity which may affect topographic assessment will be excluded (e.g. Limb length discrepancy greater than 2cm).
* Families who do not speak English and Spanish will be unable to participate as the application is only available in English and Spanish at this time.
* Families who do not have access to their own compatible personal smart phone device will be unable to participate in the study.
Minimum Eligible Age

8 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Momentum Health Inc.

INDUSTRY

Sponsor Role collaborator

Children's Hospital Los Angeles

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lindsay Andras

Attending Physician

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lindsay M Andras, MD

Role: PRINCIPAL_INVESTIGATOR

Children's Hospital Los Angeles

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tiffany Phan, BA

Role: CONTACT

3234612142

Lindsay M Andras, MD

Role: CONTACT

323-361-2148

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHLA-24-00371

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

MR-HIFU Treatment of Painful Osteoid Osteoma
NCT04658771 ACTIVE_NOT_RECRUITING PHASE2
Resiliency Training in Adolescents With NF1 and NF2
NCT03873610 ACTIVE_NOT_RECRUITING NA